查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1563854

败血症诊断的全球市场

Sepsis Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 173 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球败血症诊断市场预计将达到 12 亿美元

败血症诊断的全球市场预计 2023 年为 6.963 亿美元，预计到 2030 年将达到 12 亿美元，在 2023-2030 年分析期间复合年增长率为 7.5%。微生物技术是本报告分析的细分市场之一，预计复合年增长率为 9.0%，到分析期结束时将达到 7.498 亿美元。分析期内，免疫测量技术领域的复合年增长率预计为4.8%。

美国市场预估价值1.84亿美元，中国预期复合年增长率12.7%

预计 2023 年美国脓毒症诊断市场规模将达 1.84 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达2.994亿美元，2023-2030年分析期间复合年增长率为12.7%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 3.0% 和 7.4%。在欧洲，德国的复合年增长率预计为 3.9%。

全球败血症诊断市场－主要趋势与驱动因素总结

为什么对先进脓毒症诊断的需求激增？

败血症是一种危及生命的疾病，是由身体对感染的极端反应引起的，并且仍然是全世界死亡的主要原因。对先进脓毒症诊断的需求正在迅速增加，因为早期检测和及时干预对于改善患者治疗结果和降低医疗成本至关重要。传统的诊断方法常常面临脓毒症早期检测的时间延迟、准确性和复杂性等挑战。为此，医院和临床实验室越来越多地实施创新的诊断解决方案，例如分子诊断、快速抗原检测和基于生物标记的检测，以实现败血症的准确和快速诊断。败血症的高盛行率，特别是在加护病房(ICU) 和急诊科，进一步支持了这些先进诊断工具的全球采用。

技术进步如何影响败血症诊断？

技术进步显着改善了败血症诊断的前景，提供了更高的准确性、速度和可靠性。分子诊断的创新，包括聚合酵素链锁反应(PCR) 和次世代定序(NGS)，能够快速识别病原体及其抗生素抗药性特征，从而促进标靶治疗。此外，自动化平台和照护现场(POC) 设备的发展使诊断能力更接近床边，缩短了获得结果的时间并改善了临床决策。人工智慧和机器学习演算法也被纳入诊断工具中，以分析复杂的资料集并更准确地预测败血症结果。此外，抑钙素(PCT)、CRP 和乳酸水平等基于生物标誌物的检测的兴起为临床医生提供了有关脓毒症严重程度和进展的重要信息，推动了先进诊断市场的发展。

哪些细分市场正在引领脓毒症诊断的采用？

败血症诊断市场按技术、产品类型、病原体、测试类型、最终用户和地区进行细分。关键技术包括分子诊断、免疫检测、微生物学和流式细胞技术，其中分子诊断因其能够快速、准确地识别病原体而引领市场。产品类型从设备和试剂到软体和服务，但由于经常性需求，试剂和耗材占最大份额。败血症诊断的目标病原体包括细菌、真菌和病毒病原体，其中细菌病原体是最常见的，因为临床环境中细菌感染的发生率很高。脓毒症诊断的最终用户包括医院、病理实验室和研究机构，其中医院由于 ICU 和急诊室脓毒症病例数量较多而占据市场主导地位。从地区来看，北美和欧洲由于先进的医疗基础设施和较高的认识而成为主要市场，而亚太地区由于医疗投资的增加和对脓毒症的认识的提高，正在成为一个高增长地区。

败血症诊断市场的成长促进因素有哪些？

败血症诊断市场的成长受到多种因素的推动，例如败血症盛行率的增加、对快速准确诊断工具的需求以及基于分子和生物标记的诊断的进步。在短时间内提供高灵敏度的照护现场设备和自动化平台的开拓正在推动医院和诊断实验室的市场采用。对个人化医疗和标靶治疗的日益关注正在扩大先进败血症诊断的使用，从而实现准确的病原体识别和抗生素敏感性测试。旨在降低死亡率和改善脓毒症早期检测的政府倡议和医疗保健计划的不断增加正在为市场成长创造新的机会。此外，增加对新型脓毒症生物标记、基于人工智慧的诊断工具和快速多重检测的研发投资正在进一步推动市场扩张。

受访的公司范例（所有 46 家有兴趣的公司）

  • Abbott Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bruker Corporation
  • Cytosorbents Corporation
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • Immunexpress Inc.
  • Luminex Corporation
  • Mitsubishi Chemical Europe
  • Response Biomedical Corp.
  • Roche Diagnostics（Schweiz）AG
  • T2 Biosystems
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP14671

Global Sepsis Diagnostics Market to Reach US$1.2 Billion by 2030

The global market for Sepsis Diagnostics estimated at US$696.3 Million in the year 2023, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Microbiology Technology, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$749.8 Million by the end of the analysis period. Growth in the Immunoassay Technology segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$184.0 Million While China is Forecast to Grow at 12.7% CAGR

The Sepsis Diagnostics market in the U.S. is estimated at US$184.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$299.4 Million by the year 2030 trailing a CAGR of 12.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Sepsis Diagnostics Market - Key Trends and Drivers Summarized

Why Is the Demand for Advanced Sepsis Diagnostics Growing Rapidly?

Sepsis, a life-threatening condition resulting from the body’s extreme response to infection, remains a leading cause of mortality worldwide. The demand for advanced sepsis diagnostics is rapidly increasing due to the need for early detection and timely intervention, which are critical for improving patient outcomes and reducing healthcare costs. Traditional diagnostic methods often face challenges related to time delays, accuracy, and the complexity of identifying sepsis at an early stage. In response, hospitals and clinical laboratories are increasingly adopting innovative diagnostic solutions, such as molecular diagnostics, rapid antigen tests, and biomarker-based assays, to enable precise and swift diagnosis of sepsis. The high prevalence of sepsis, particularly in intensive care units (ICUs) and emergency departments, is further driving the adoption of these advanced diagnostic tools globally.

How Are Technological Advancements Impacting Sepsis Diagnostics?

Technological advancements are significantly enhancing the sepsis diagnostics landscape, offering greater accuracy, speed, and reliability. Innovations in molecular diagnostics, including polymerase chain reaction (PCR) and next-generation sequencing (NGS), are enabling rapid identification of pathogens and their antibiotic resistance profiles, facilitating targeted therapy. Additionally, the development of automated platforms and point-of-care (POC) devices is bringing diagnostic capabilities closer to the bedside, reducing the time-to-results and improving clinical decision-making. AI and machine learning algorithms are also being integrated into diagnostic tools to analyze complex datasets and predict sepsis outcomes more accurately. Furthermore, the rise of biomarker-based tests, such as procalcitonin (PCT), C-reactive protein (CRP), and lactate levels, is providing clinicians with critical information on the severity and progression of sepsis, driving the market for advanced diagnostics.

Which Market Segments Are Leading the Adoption of Sepsis Diagnostics?

The sepsis diagnostics market is segmented by technology, product type, pathogen, testing type, end-user, and region. Key technologies include molecular diagnostics, immunoassays, microbiology, and flow cytometry, with molecular diagnostics leading due to their rapid and precise pathogen identification capabilities. Product types range from instruments and reagents to software and services, with reagents and consumables accounting for the largest share owing to their recurring demand. Pathogens covered in sepsis diagnostics include bacterial, fungal, and viral pathogens, with bacterial sepsis diagnostics being the most common due to the high incidence of bacterial infections in clinical settings. End-users of sepsis diagnostics include hospitals, pathology labs, and research institutes, with hospitals dominating the market due to the high volume of sepsis cases in ICUs and emergency departments. Geographically, North America and Europe are the leading markets due to advanced healthcare infrastructure and high awareness, while Asia-Pacific is emerging as a high-growth region driven by increasing healthcare investments and rising sepsis awareness.

What Are the Key Drivers of Growth in the Sepsis Diagnostics Market?

The growth in the sepsis diagnostics market is driven by several factors, including the increasing prevalence of sepsis, the need for rapid and accurate diagnostic tools, and advancements in molecular and biomarker-based diagnostics. The development of point-of-care devices and automated platforms that provide quick turnaround times and high sensitivity is driving market adoption across hospitals and diagnostic labs. The growing focus on personalized medicine and targeted therapies is expanding the use of advanced sepsis diagnostics that enable precise pathogen identification and antibiotic susceptibility testing. The rise of government initiatives and healthcare programs aimed at reducing sepsis mortality rates and improving early detection is creating new opportunities for market growth. Additionally, the increasing investments in R&D for novel sepsis biomarkers, AI-based diagnostic tools, and rapid multiplex assays are further supporting market expansion.

Select Competitors (Total 46 Featured) -

  • Abbott Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bruker Corporation
  • Cytosorbents Corporation
  • Danaher Corporation
  • EKF Diagnostics Holdings PLC
  • Immunexpress Inc.
  • Luminex Corporation
  • Mitsubishi Chemical Europe
  • Response Biomedical Corp.
  • Roche Diagnostics (Schweiz) AG
  • T2 Biosystems
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Sepsis Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Sepsis Cases Globally Spurs Demand for Advanced Diagnostic Solutions
    • Technological Advancements in Molecular Diagnostics Propel Innovation in Sepsis Testing
    • Increasing Focus on Early Detection and Rapid Diagnosis Expands Addressable Market Opportunity
    • Growth of Point-of-Care Testing (POCT) for Sepsis Strengthens Business Case for Diagnostic Tools
    • Focus on Enhancing Sensitivity and Specificity of Sepsis Diagnostic Tests Drives Adoption
    • Emergence of Automated and AI-Driven Diagnostic Systems Generates New Market Opportunities
    • Rising Use of Biomarker-Based Diagnostics in Sepsis Detection Boosts Market Potential
    • Shift Towards Personalized Medicine and Targeted Therapies Expands Market Reach
    • Growing Emphasis on Sepsis Management in Critical Care Units Spurs Market Innovation
    • Emergence of Sepsis Diagnostics as a Key Component in Antimicrobial Stewardship Programs Expands Adoption
    • Expansion of Diagnostic Applications in Low- and Middle-Income Countries Creates New Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sepsis Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sepsis Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Molecular Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Molecular Diagnostic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Molecular Diagnostic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Blood Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Blood Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Blood Culture Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Assay Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Assay Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Assay Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Point-of-Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Point-of-Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Point-of-Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • JAPAN
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • CHINA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • EUROPE
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Sepsis Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • FRANCE
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • GERMANY
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Sepsis Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • INDIA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Sepsis Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Sepsis Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Sepsis Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030
  • AFRICA
    • Sepsis Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Sepsis Diagnostics by Technology - Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Sepsis Diagnostics by Technology - Percentage Breakdown of Value Sales for Microbiology, Immunoassay, Molecular Diagnostic and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Sepsis Diagnostics by Product - Blood Culture Media, Assay Kits & Reagents, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Sepsis Diagnostics by Product - Percentage Breakdown of Value Sales for Blood Culture Media, Assay Kits & Reagents, Instruments and Software for the Years 2014, 2024 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Sepsis Diagnostics by Testing Type - Laboratory and Point-of-Care Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Sepsis Diagnostics by Testing Type - Percentage Breakdown of Value Sales for Laboratory and Point-of-Care for the Years 2014, 2024 & 2030

IV. COMPETITION